Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-06-12 9:10 pm Sale | 2025-06-10 | 13D | BioLife Solutions, Inc. BLFS | Casdin Capital, LLC | 7,707,165 16.200% | -1,027,994 (-11.77%) | Filing History |
| 2025-04-09 5:13 pm Purchase | 2025-04-07 | 13D | BioLife Solutions, Inc. BLFS | Casdin Capital, LLC | 8,735,159 18.500% | 27,994 (+0.32%) | Filing History |
| 2024-11-08 09:59 am Purchase | 2024-11-08 | 13G | BioLife Solutions, Inc. BLFS | Invesco Ltd. IVZ | 3,203,293 7.000% | 3,203,293 (New Position) | Filing History |
| 2024-11-01 4:19 pm Sale | 2024-09-30 | 13G | BioLife Solutions, Inc. BLFS | GOLDMAN SACHS GROUP INC GS | 161,488 0.400% | -2,314,754 (-93.48%) | Filing History |
| 2024-02-13 5:00 pm Purchase | 2023-12-29 | 13G | BioLife Solutions, Inc. BLFS | The Vanguard Group | 2,571,608 5.710% | 104,677 (+4.24%) | Filing History |
| 2024-02-02 10:11 am Purchase | 2023-12-29 | 13G | BioLife Solutions, Inc. BLFS | GOLDMAN SACHS GROUP INC GS | 2,476,242 5.500% | 2,476,242 (New Position) | Filing History |
| 2024-01-24 4:16 pm Sale | 2023-12-31 | 13G | BioLife Solutions, Inc. BLFS | Integrated Core Strategies (US) LLC | 2,412,650 5.400% | -69,296 (-2.79%) | Filing History |
| 2024-01-23 4:13 pm Sale | 2023-12-31 | 13G | BioLife Solutions, Inc. BLFS | BlackRock Inc. BLK | 5,424,116 12.300% | -53,010 (-0.97%) | Filing History |
| 2023-10-24 4:29 pm Purchase | 2023-10-19 | 13D | BioLife Solutions, Inc. BLFS | Casdin Capital, LLC | 8,707,165 19.500% | 1,267,058 (+17.03%) | Filing History |
| 2023-09-26 4:26 pm Purchase | 2023-09-18 | 13G | BioLife Solutions, Inc. BLFS | Integrated Core Strategies (US) LLC | 2,481,946 5.700% | 2,481,946 (New Position) | Filing History |
| 2023-02-09 11:12 am Purchase | 2022-12-30 | 13G | BioLife Solutions, Inc. BLFS | The Vanguard Group | 2,466,931 5.770% | 319,673 (+14.89%) | Filing History |
| 2023-01-26 08:52 am Unchanged | 2022-12-31 | 13G | BioLife Solutions, Inc. BLFS | BlackRock Inc. BLK | 5,477,126 12.800% | 0 (Unchanged) | Filing History |
| 2023-01-20 09:43 am Purchase | 2022-12-31 | 13G | BioLife Solutions, Inc. BLFS | BlackRock Inc. BLK | 5,477,126 12.800% | 583,923 (+11.93%) | Filing History |
| 2023-01-11 4:20 pm Sale | 2022-12-31 | 13G | BioLife Solutions, Inc. BLFS | Millennium Management LLC | 670,202 1.600% | -1,496,142 (-69.06%) | Filing History |
| 2022-07-08 4:56 pm Purchase | 2022-06-30 | 13G | BioLife Solutions, Inc. BLFS | BlackRock Inc. BLK | 4,893,203 11.500% | 1,238,146 (+33.87%) | Filing History |
| 2022-06-22 4:37 pm Purchase | 2022-06-16 | 13G | BioLife Solutions, Inc. BLFS | Millennium Management LLC | 2,166,344 5.100% | 2,166,344 (New Position) | Filing History |
| 2022-02-09 3:33 pm Purchase | 2021-12-31 | 13G | BioLife Solutions, Inc. BLFS | The Vanguard Group | 2,147,258 5.160% | 2,147,258 (New Position) | Filing History |
| 2022-02-01 5:08 pm Sale | 2021-12-31 | 13G | BioLife Solutions, Inc. BLFS | BlackRock Inc. BLK | 3,655,057 8.800% | -873,666 (-19.29%) | Filing History |
| 2021-10-29 8:00 pm Sale | 2021-08-26 | 13D | BioLife Solutions, Inc. BLFS | VILLIGER WALTER | 1,979,226 4.860% | -1,023,754 (-34.09%) | Filing History |
| 2021-09-09 4:20 pm Purchase | 2021-08-31 | 13G | BioLife Solutions, Inc. BLFS | BlackRock Inc. BLK | 4,528,723 11.100% | 4,528,723 (New Position) | Filing History |